Fredrik Bäckström

Nessuna posizione attualmente

Patrimonio netto: 33 957 $ in data 31/03/2024

59 anni

Producer Manufacturing

Electronic Technology

Profilo

Fredrik Bäckström worked as the Vice President-Product Supply at Arcam AB from 2013 to 2019.
He also held the position of Vice President-Manufacturing & Supply at Carmel Pharma AB from 2000 to 2011.
Currently, he is serving as the Chief Operating Officer at Bulten AB, a position he started in 2019 and will continue until 2023.

Partecipazioni note in società pubbliche

Società	Data	Numero di azioni	Valorizzazione	Data di valutazione
BULTEN AB 0.02%	25/08/2023	4 940 ( 0.02% )	33 957 $	31/03/2024

Precedenti posizioni note di Fredrik Bäckström

Società	Posizione	Fine
BULTEN AB	Chief Operating Officer	01/08/2023
ARCAM AB (PUBL)	Corporate Officer/Principal	01/12/2019
Carmel Pharma AB Carmel Pharma AB Electronic Equipment/InstrumentsElectronic Technology Carmel Pharma AB manufactures PhaSeal System, a clinically proven closed-system drug transfer device (CSTD) for the safe handling of hazardous drugs. The company expanded its safe handling initiatives to the U.S. market with the formation of Carmel Pharma, Inc., which operates a corporate office and distribution facility out of Columbus, OH. Carmel Pharma AB was founded in 1994 and is headquartered in Gothenburg, Sweden.	Corporate Officer/Principal	-

Vedi nel dettaglio l'esperienza di Fredrik Bäckström

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Fredrik Bäckström

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
BULTEN AB	Producer Manufacturing

Aziende private	2
Arcam AB Arcam AB Industrial MachineryProducer Manufacturing Arcam AB engages in the development and commercialization of technologies for metal-based, freedom-in-design manufacturing. It develops, manufactures, and sells equipment and methods for Additive Manufacturing in metal. The company was founded in 1997 and is headquartered in Molndal, Sweden.	Producer Manufacturing
Carmel Pharma AB Carmel Pharma AB Electronic Equipment/InstrumentsElectronic Technology Carmel Pharma AB manufactures PhaSeal System, a clinically proven closed-system drug transfer device (CSTD) for the safe handling of hazardous drugs. The company expanded its safe handling initiatives to the U.S. market with the formation of Carmel Pharma, Inc., which operates a corporate office and distribution facility out of Columbus, OH. Carmel Pharma AB was founded in 1994 and is headquartered in Gothenburg, Sweden.	Electronic Technology